Skip to main content

Table 2 The prevalence of gastrointestinal disorders within the groups and compared using the odds ratios

From: Constipation in adults with neurofibromatosis type 1

 

NF1 patients (n = 175)

Controls (n = 91)

Odds ratio, p, crude

Odds ratio, p, adjusted for age and gender

Functional gastrointestinal disordera

33.1% (CI: 26.2–40.1)

14.3% (CI: 7.7–20,8)

2.97 (CI: 1.56–5.66), 0.001

3.06 (CI: 1.62–5.79), 0.001

Functional constipation

14.9% (CI: 9.6–20.1)

4.4% (CI: 0.02–8.6)

3.80 (CI: 1.27–11.31), 0.017

3.49 (CI: 1.14–10.64), 0.028

Irritable bowel syndrom

16.0% (CI: 10.6–21.4)

7.7% (CI: 0.03–12.9)

2.29 (CI: 0.98–5.33), 0.056

2.46 (CI: 1.10–5.47), 0.028

Functional dyspepsia

7.4% (CI: 3.5–11.3)

3.3% (CI: 0–6.9)

2.35 (CI: 0.67–8.32), 0.184

2.25 (CI: 0.70–7.17), 0.170

  1. NF1 neurofibromatosis type 1, CI 95% Confidence Interval, p p-value
  2. aAny of the three; functional dyspepsia, IBS or functional constipation
  3. Legend: The prevalence reported within the group of patients with NF1 and the control group and compared using the odds ratio